Pharming Group N.V. announced its promotion from the Euronext AScX® (Small Cap) to the AMX® (MidCap) index, effective from September 22, 2025. This marks Pharming’s return to the AMX index.
Euronext Amsterdam's review of the AMX index, which comprises 25 companies based on free-float market capitalization and liquidity, led to this promotion. The move reflects the company’s sustained growth and increasing market presence.
This promotion is significant for investors as it typically leads to increased visibility and liquidity for the company's shares, potentially attracting a wider base of institutional investors and reflecting a stronger market position.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.